Biomedical Sciences
Global

Biomedical Sciences Experts

Yoshiaki Tsukamoto

executive director of the Japan Bioindustry Associ
Bioorganic and medicinal chemistry
BioMolTech
Aruba

Biography

Prof. Yoshiaki Tsukamoto, executive director of the Japan Bioindustry Association (JBA), talked exclusively to PharmaBoardroom at the BIO 2017 conference in San Diego on the role of his organization within Japan and his mission to instill a start-up culture within the Japanese biopharmaceutical industry. Japan is widely regarded as one of the most innovative countries in the world. In terms of the life sciences, Japan is strongest in basic research and Japanese scientists have been recognized for their groundbreaking contributions, with 25 Nobel Prize winners since 1949, 17 of which have come in the 21st century. However, bringing Japanese innovations to market has traditionally been a tricky prospect. As Prof. Tsukamoto highlights, 20 years ago when working at the Tokyo Institute of Technology and attempting to promote collaboration between academia and industry as well as technology transfer, “Japan was far away from open innovation and universities did not want to engage in technology transfer; they wanted their only focus to be on research.”

Research Interest

Prof. Yoshiaki Tsukamoto, executive director of the Japan Bioindustry Association (JBA), talked exclusively to PharmaBoardroom at the BIO 2017 conference in San Diego on the role of his organization within Japan and his mission to instill a start-up culture within the Japanese biopharmaceutical industry. Japan is widely regarded as one of the most innovative countries in the world. In terms of the life sciences, Japan is strongest in basic research and Japanese scientists have been recognized for their groundbreaking contributions, with 25 Nobel Prize winners since 1949, 17 of which have come in the 21st century. However, bringing Japanese innovations to market has traditionally been a tricky prospect. As Prof. Tsukamoto highlights, 20 years ago when working at the Tokyo Institute of Technology and attempting to promote collaboration between academia and industry as well as technology transfer, “Japan was far away from open innovation and universities did not want to engage in technology transfer; they wanted their only focus to be on research.”

Global Experts from Aruba

Global Experts in Subject

Share This Profile
Recommended Conferences
  • 8th World congress on Clinical Trials & Regulatory Affairs Nov 21-22, 2018 Paris, France

    Nov 21-22, 2018 Paris, France

  • 8th World congress on Clinical Trials & Regulatory Affairs

    Nov 21-22, 2018 Paris, France

  • 5th Annual Congress and Medicare Expo on Trauma & Critical Care March 05-06, 2019 Amsterdam, Netherlands

    March 05-06, 2019 Amsterdam, Netherlands

  • 2nd Annual Summit on Cell Therapy and Regenerative Medicine November 9-10, 2018 Atlanta, Georgia, USA

    November 9-10, 2018 Atlanta, USA

View more